James M. Mock - 05 Oct 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
Brian Sandstrom, As Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
05 Oct 2022
Transactions value $
$0
Form type
4
Filing time
07 Oct 2022, 16:07:10 UTC
Previous filing
09 Sep 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Award $0 +43.9K $0.00 43.9K 05 Oct 2022 Common Stock 43.9K $125.62 Direct F1
transaction MRNA Restricted Stock Units Award $0 +23.2K $0.00 23.2K 05 Oct 2022 Common Stock 23.2K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option will vest and become exercisable on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to this restricted stock unit award will vest on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.